Albers Jeffrey W. - Insider Non-Derivative Transactions at Kymera Therapeutics, Inc. (KYMR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 26, 2024, Albers Jeffrey W.'s relationship to Kymera Therapeutics, Inc. (KYMR) is Director, and currently has 5,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KYMR insiders.
Data Source: SEC.
Albers Jeffrey W. - Insider Non-Derivative Transactions of KYMR Common Stock
Albers Jeffrey W. - Insider Non-Derivative Transactions at KYMR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 27, 2024 | Sell -- (Common Stock) | 5000 | 49.1 | 0 |
| Aug 27, 2024 | M -- (Common Stock) | 5000 | 10.34 | 5000 |
| Feb 22, 2024 | Sell -- (Common Stock) | 4385 | 39.05 | 0 |
| Feb 22, 2024 | M -- (Common Stock) | 4385 | 10.34 | 4385 |
| Feb 21, 2024 | Sell -- (Common Stock) | 615 | 39.07 | 0 |
| Feb 21, 2024 | M -- (Common Stock) | 615 | 10.34 | 615 |
| Jan 24, 2024 | Sell -- (Common Stock) | 10000 | 30.05 | 0 |
| Jan 24, 2024 | M -- (Common Stock) | 10000 | 10.34 | 10000 |